[1] Gundesen M T,Lund T,Moeller HEH,et al. Plasma cell leukemia: definition,presentation,and treatment[J]. Curr oncol rep,2019,
21(1):8
[2] Fernández de Larrea C,Kyle R A,Durie B G,et al. Plasma cell leukemia: consensus statement on diagnostic requirements,response criteria and treatment recommendations by the International Myeloma Working Group [J]. Leukemia,2013,27(4):780
[3] 王欢,李建勇,孙超,等. 原发浆细胞白血病诊疗进展[J]. 中国实验血液学杂志,2017,25(6):1837
[4] Peijing Q,Yan X,Yafei W,et al. A retrospective analysis of thirty-one cases of plasma cell leukemia from a single center in China[J]. Acta haematol,2009,121(1):47
[5] Katodritou E,Terpos E,Delimpasi S,et al. Real-world data on prognosis and outcome of primary plasma cell leukemia in the era of novel agents: a multicenter national study by the Greek Myeloma Study Group[J]. Blood cancer J,2018,8(3):31
[6] 李玲义,吴涛,薛锋,等. 以乏力伴发热为首发临床表现的原发性浆细胞白血病一例并文献复习[J]. 中国医师进修杂志,2018, 41(12):1129
[7] Tiedemann R E,Gonzalez-Paz N,Kyle R A,et al. Genetic aberrations and survival in plasma cell leukemia[J]. Leukemia,2008,22(5):1044
[8] Jung S H,Lee J J,Kim K,et al. The role of frontline autologous stem cell transplantation for primary plasma cell leukemia: a retrospective multicenter study(KMM160)[J]. Oncotarget,2017,8(45):79517